foxo4 dri senolytic peptide human trial 2024 2025 Buy FOXO4-DRI (Proxofim) Frontiers | FOXO4-DRI regulates endothelial
Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Senescent cells as a target for anti aging interventions: From senolytics to immune therapies PMC Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Pay in 4 interest-free payments of $5.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12





